Meridian Wealth Management’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
Other funds holding NVO
F
Meridian Wealth Management's NVO Position: Q2 2026 in Review
Meridian Wealth Management reduced its Novo Nordisk (NVO) stake by 30% in Q2 2026, selling an estimated $169K and leaving 9,208 shares worth $441K. The position accounts for 0.01% of the portfolio, ranked #580.
Meridian Wealth Management first reported a position in NVO in Q2 2019 and has held it in 17 quarters since. The position peaked at $15.1M in Q3 2024. 1,353 funds tracked by Wall St. Rank hold NVO as of Q2 2026.
- Meridian Wealth Management held 9,208 shares of Novo Nordisk worth $441K as of Q2 2026.
- Meridian Wealth Management sold 3,937 Novo Nordisk shares in Q2 2026, an estimated $169K.
- Novo Nordisk made up 0.01% of Meridian Wealth Management's portfolio in Q2 2026, its #580 holding.
- Meridian Wealth Management first reported a position in Novo Nordisk in Q2 2019 and has held it in 17 quarters since.
- Meridian Wealth Management's Novo Nordisk position peaked at $15.1M in Q3 2024.
- 1,353 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.
Based on Meridian Wealth Management's 13F filing for Q2 2026, filed 5 Aug 2026.